HOME >> BIOLOGY >> NEWS
Predictive testing for hereditary breast and ovarian cancer: its effect on women

One in ten women opted to have prophylactic mastectomy and nearly half opted to have their ovaries removed in the year following genetic tests which showed they were at risk of hereditary breast and ovarian cancer (HBOC), a Belgian clinical psychologist reported at the 3rd European Breast Cancer Conference in Barcelona today (Wednesday 20 March).

However Ms Erna Claes, who is studying the impact of predictive testing for HBOC, found that women who had been diagnosed as carriers were not significantly more or less distressed after the results of the predictive genetic testing than women who were found not to be carriers. Nor were there significant differences in distress levels before and after the results of genetic testing in either carriers or non-carriers, according to Ms Claes, a clinical psychologist at the Psychosocial Genetics Unit in Leuven, Belgium.

Instead the carriers took practical measures, following the screening recommendations and opting for regular medical examinations. About 10% had a prophylactic mastectomy within a year of the test result. Of the women who were carriers and aged over 35, 37% had had their ovaries removed (oophorectomy) before applying for predictive testing and 44% had prophylactic oophorectomy after the testing.

Ms Claes said there could be a number of reasons why the women reacted in the way that they did. Within our current study group, only a minority of women have chosen to have a prophylactic mastectomy so far. The majority seem to find this procedure too far reaching or consider it will have too much impact on their lives, their partner or their sexual relations. However, long-term follow-up results are needed in order to see whether more women will choose to have prophylactic mastectomy after the predictive genetic test result. It is possible that what happens in their families could have an impact on their choice, for instance if their sister, mother or aunt is diagnosed with breast or ovar
'"/>

Contact: Emma Mason
wordmason@aol.com
44-7711-296-986
Federation of European Cancer Societies
20-Mar-2002


Page: 1 2 3

Related biology news :

1. Far more men than women favor routine paternity testing at birth
2. Nucleic acid-amplification testing further safeguards nations blood supply
3. Clinical judgement still counts strongly alongside genetic testing
4. Genetic testing of embryos to pick savior sibling OK with most Americans
5. Annual bioethics forum to explore genetic testing
6. New toxicity test could cut animal testing
7. Revised guidelines published for testing for hereditary type of colorectal cancer
8. Study calls for end to age thresholds for prenatal genetic testing
9. Genetic testing of embryos
10. HPV testing could be future strategy for primary screening for cervical cancer
11. High-risk women welcome genetic testing for breast cancer gene

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2020)... ... May 19, 2020 , ... ... operations management solutions, today introduced BioMed to their award-winning computerized maintenance management ... connecting the people and systems around biomedical engineering to better allocate staff ...
(Date:5/21/2020)... Mass. (PRWEB) , ... May 21, 2020 , ... ... orthopedic care across the North Shore and Greater Boston area, is pleased to ... , As one of the busiest group practices in the area, Agility Orthopedics ...
(Date:5/14/2020)... Kan. (PRWEB) , ... May 13, 2020 , ... ... American launch of Bonlacta™, its latest enzyme for the lactose-free dairy market. This ... a wide range of lactose-free dairy products at competitive costs across North America. ...
Breaking Biology News(10 mins):
(Date:5/5/2020)... Fla. (PRWEB) , ... May 05, 2020 , ... ... and solutions company, announced today the launch of its iGlucose® LTE ... new iGlucose solution utilizes LTE Cat-M1 technology, the industry’s newest and broadest cellular ...
(Date:4/22/2020)... (PRWEB) , ... April 20, 2020 , ... ... offices in Cambridge, MA, announced today that Omixon’s founder and chairman Dr. Attila ... of Omixon’s flagship product Holotype HLA since 2014 before stepping into the CEO ...
(Date:4/7/2020)... ... 2020 , ... Gateway Genomics , leading developer of direct-to-consumer genetic tests ... DNA Tests sold in March, just months after attaining the 150,000-test landmark in ... a mom could order her kit online, collect a DNA sample from her home, ...
(Date:4/1/2020)... GOES, Netherlands (PRWEB) , ... ... ... company, Molecular Biology Systems, B.V. (MBS) has developed a method using its ... SARS-CoV-2 to eight minutes. Combined with smaller reaction volumes, increased samples per ...
Breaking Biology Technology:
Cached News: